Consumer Health Cancer / Immunology
Arcus and AstraZeneca Partner to Evaluate Novel Combination Therapy for Advanced Renal Cell Carcinoma
Arcus and AstraZeneca to evaluate their respective molecules in combination to establish a potential first- and best-in-class treatment for clear c...
October 03, 2024 | News
NUS Researchers Introduce TETRIS Technology to Transform Cancer Diagnostics and Personalized Treatment
Scalable and adaptable, TETRIS captures the diversity of protein interactions on site to inform accurate cancer diagnoses, enabling the personalisation of ...
October 01, 2024 | News
Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation (HKBCF), launched its 16th annual research report&nbs...
September 30, 2024 | News
Anbogen Partners with BeiGene to Launch Global Phase II Trial for Innovative Colorectal Cancer Treatment
Anbogen, a clinical-stage biotech company, announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with Bei...
September 30, 2024 | News
BioCina Partners with EnGeneIC to Accelerate Manufacturing of Cutting-Edge Cancer Treatment
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with drug deve...
September 25, 2024 | News
The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
This is especially concerning in Asia, where rates of illness are expected to rise in the coming years. When it comes to breast cancer, for instance, Asia ...
September 20, 2024 | Opinion | By Deepti Saraf General Manager, Roche (Malaysia) Sdn. Bhd.
Full-Life Technologies Secures $571.5M Licensing Deal with SK Biopharmaceuticals for Anti-Cancer Radiopharmaceutical FL-091
Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' ra...
September 19, 2024 | News
Massive Bio Launches Free AI-Powered Portal to Simplify Cancer Clinical Trial Enrollment for Patients Worldwide
Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovati...
September 17, 2024 | News
Johnson & Johnson’s TAR-200 Shows Promising Results in BCG-Unresponsive Bladder Cancer in Latest Phase 2b SunRISe-1 Study
Johnson & Johnson announced additional results from its pivotal Phase 2b SunRISe-1 study, reinforcing the safety and efficacy of TAR-200, an investigat...
September 16, 2024 | News
Qritive Partners with Roche to Transform Cancer Diagnostics with AI-Powered Pathology Solutions
Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest ...
September 13, 2024 | News
GC Cell Partners with Indonesia’s Bifarma in Major Technology Transfer for Immuncell-LC Cancer Therapy
GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifa...
September 11, 2024 | News
A. Menarini Diagnostics and Nucleix Partner for Non-Invasive Bladder Cancer Test in Europe
Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe&...
September 10, 2024 | News
Arsenal Biosciences Closes $325 Million Series C Funding to Advance Next-Gen CAR T-Cell Therapies for Solid Tumors
Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...
September 05, 2024 | News
Albatroz Therapeutics Joins Johnson & Johnson Innovation – JLABS Singapore to Accelerate Cancer Therapy Development
Albatroz Therapeutics, a biotechnology company developing novel therapies against cancer and other indications, today announced its membership of Johnson &...
September 04, 2024 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
